The initiating step in CF-related alterations of cholesterol homeostasis appears to be loss of a CFTR-mediated movement of cholesterol to the plasma membrane followed by a subsequent increase in de novo cholesterol synthesis. The gene discussed is CFTR; the disease is cystic fibrosis.